Ikonisys Clinical Laboratories

Ikonisys Clinical Laboratories (ICL) is a fully licensed, CAP-accredited clinical laboratory offering early cancer and genetic disorder screening. Specializing in FISH, our menu includes both established assays and a growing family of new, unique FISH tests for rare and abnormal cell detection.

The ICL staff has exceptional expertise in FISH technology. Reproducible, accurate results with excellent turn-around time, and a demonstrated commitment to providing uniquely personalized service for our clients and their patients, define the Ikonisys Clinical Laboratories. 

FISH procedures are performed using our Ikoniscope® Digital Microscopy System that provides fully automated FISH scoring and preliminary analysis, greatly reducing subjectivity compared to manual processing. The combination of automation and scientific/medical expertise provides our clients with highly objective, reliable results.

More than a clinical laboratory
ICL is part of Ikonisys, Inc., a leader in automated FISH testing. Ikonisys is at the forefront of developing novel FISH applications to detect rare and abnormal cells. Through ICL, Ikonisys provides clients with early access to these new, high-value test solutions, enhancing patient diagnosis and management.

See our complete test menu

Licenses & Accreditations
Ikonisys Clinical Laboratories is licensed by the States of Connecticut (CL-0657), California, (COS 800244), New York (PFI 8332), Florida (800023290), Maryland (1454), Pennsylvania (030784), and Rhode Island (LCO00524), holds a certificate of accreditation from the Centers for Medicare and Medicaid Services under CLIA'88 (CLIA ID: 07D1072449), and is accredited by the College of American Pathologists (CAP LAP Number 7208011). Our NPI is 1932381159.

Download the oncoFISH cervical brochure